For a Limited Time: Get 3 Years of Access at the Price of 1
Here is the latest financial fact sheet of ACCENT MICROCELL LTD.. For more details, see the ACCENT MICROCELL LTD. quarterly results and ACCENT MICROCELL LTD. share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -1.4 |
No. of shares | m | 21.04 |
1 Week | % | 9.8 |
1 Month | % | 7.9 |
1 Year | % | - |
52 week H/L | Rs | 364.0/224.0 |
No. of Mths Year Ending |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
ACCENT MICROCELL LTD. EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | NA | NA | NA | |||
Low | Rs | NA | NA | NA | |||
Sales per share (Unadj.) | Rs | 308.3 | 128.5 | 157.8 | |||
Earnings per share (Unadj.) | Rs | 11.2 | 4.6 | 10.1 | |||
Diluted earnings per share | Rs | 2.3 | 2.8 | 6.2 | |||
Cash flow per share (Unadj.) | Rs | 19.4 | 7.8 | 13.2 | |||
Dividends per share (Unadj.) | Rs | 1.00 | 0.80 | 0.80 | |||
Adj. dividends per share | Rs | 0.20 | 0.49 | 0.49 | |||
Avg Dividend yield | % | 0 | 0 | 0 | |||
Book value per share (Unadj.) | Rs | 61.9 | 24.9 | 34.2 | |||
Adj. book value per share | Rs | 12.7 | 15.3 | 21.0 | |||
Shares outstanding (eoy) | m | 4.30 | 12.90 | 12.94 | |||
Price / Sales ratio | x | 0 | 0 | 0 | |||
Avg P/E ratio | x | 0 | 0 | 0 | |||
P/CF ratio (eoy) | x | 0 | 0 | 0 | |||
Price / Book Value ratio | x | 0 | 0 | 0 | |||
Dividend payout | % | 9.0 | 17.5 | 8.0 | |||
Avg Mkt Cap | Rs m | 0 | 0 | 0 | |||
Total wages/salary | Rs m | 69 | 76 | 87 |
ACCENT MICROCELL LTD. INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 1,326 | 1,657 | 2,042 | |||
Other income | Rs m | 22 | 18 | 28 | |||
Total revenues | Rs m | 1,348 | 1,675 | 2,070 | |||
Gross profit | Rs m | 107 | 130 | 194 | |||
Depreciation | Rs m | 36 | 41 | 41 | |||
Interest | Rs m | 34 | 31 | 25 | |||
Profit before tax | Rs m | 60 | 76 | 155 | |||
Minority Interest | Rs m | 0 | 0 | 0 | |||
Prior Period Items | Rs m | 0 | 0 | 0 | |||
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | |||
Tax | Rs m | 12 | 17 | 25 | |||
Profit after tax | Rs m | 48 | 59 | 130 | |||
Gross profit margin | % | 8.1 | 7.8 | 9.5 | |||
Effective tax rate | % | 20.0 | 22.3 | 16.0 | |||
Net profit margin | % | 3.6 | 3.6 | 6.4 |
ACCENT MICROCELL LTD. BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 498 | 639 | 823 | |||
Current liabilities | Rs m | 348 | 539 | 626 | |||
Net working cap to sales | % | 11.3 | 6.0 | 9.6 | |||
Current ratio | x | 1.4 | 1.2 | 1.3 | |||
Inventory Days | Days | 2 | 1 | 3 | |||
Debtors Days | Days | 347 | 375 | 428 | |||
Net fixed assets | Rs m | 310 | 307 | 318 | |||
Share capital | Rs m | 43 | 129 | 129 | |||
"Free" reserves | Rs m | 223 | 192 | 313 | |||
Net worth | Rs m | 266 | 321 | 442 | |||
Long term debt | Rs m | 178 | 69 | 55 | |||
Total assets | Rs m | 807 | 946 | 1,141 | |||
Interest coverage | x | 2.8 | 3.5 | 7.1 | |||
Debt to equity ratio | x | 0.7 | 0.2 | 0.1 | |||
Sales to assets ratio | x | 1.6 | 1.8 | 1.8 | |||
Return on assets | % | 10.1 | 9.5 | 13.6 | |||
Return on equity | % | 18.0 | 18.4 | 29.4 | |||
Return on capital | % | 21.1 | 27.3 | 36.3 | |||
Exports to sales | % | 63.9 | 65.2 | 63.3 | |||
Imports to sales | % | 10.9 | 4.1 | 3.6 | |||
Exports (fob) | Rs m | 847 | 1,080 | 1,292 | |||
Imports (cif) | Rs m | 144 | 68 | 74 | |||
Fx inflow | Rs m | 847 | 1,080 | 1,292 | |||
Fx outflow | Rs m | 152 | 72 | 93 | |||
Net fx | Rs m | 695 | 1,008 | 1,198 |
ACCENT MICROCELL LTD. CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 50 | 149 | 78 | |||
From Investments | Rs m | -63 | -43 | -43 | |||
From Financial Activity | Rs m | -22 | -97 | -43 | |||
Net Cashflow | Rs m | -34 | 9 | -8 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Vasant Vadilal Patel | COMP SEC: Braham Pal Chhabra | YEAR OF INC: 2012 | NSE CODE: 100030 | FV (Rs): 10 | DIV YIELD (%): 0.3 |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare ACCENT MICROCELL LTD. With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
On Friday, Indian share markets traded on a positive note throughout the trading session and ended higher.